Logo image of COR

CENCORA INC (COR) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:COR - US03073E1055 - Common Stock

335.74 USD
-4.67 (-1.37%)
Last: 1/8/2026, 8:04:00 PM
339.2 USD
+3.46 (+1.03%)
After Hours: 1/8/2026, 8:04:00 PM
Fundamental Rating

5

COR gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. COR has an average financial health and profitability rating. COR has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

COR had positive earnings in the past year.
In the past year COR had a positive cash flow from operations.
COR had positive earnings in each of the past 5 years.
Each year in the past 5 years COR had a positive operating cash flow.
COR Yearly Net Income VS EBIT VS OCF VS FCFCOR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B

1.2 Ratios

COR has a Return On Assets (2.03%) which is in line with its industry peers.
COR has a Return On Equity of 103.06%. This is amongst the best in the industry. COR outperforms 98.02% of its industry peers.
COR has a better Return On Invested Capital (14.50%) than 92.08% of its industry peers.
COR had an Average Return On Invested Capital over the past 3 years of 15.04%. This is significantly above the industry average of 9.21%.
Industry RankSector Rank
ROA 2.03%
ROE 103.06%
ROIC 14.5%
ROA(3y)2.36%
ROA(5y)2.55%
ROE(3y)223.66%
ROE(5y)N/A
ROIC(3y)15.04%
ROIC(5y)14.55%
COR Yearly ROA, ROE, ROICCOR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500 -500

1.3 Margins

With a Profit Margin value of 0.48%, COR perfoms like the industry average, outperforming 51.49% of the companies in the same industry.
COR's Profit Margin has declined in the last couple of years.
The Operating Margin of COR (1.17%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of COR has grown nicely.
COR has a worse Gross Margin (3.51%) than 79.21% of its industry peers.
In the last couple of years the Gross Margin of COR has grown nicely.
Industry RankSector Rank
OM 1.17%
PM (TTM) 0.48%
GM 3.51%
OM growth 3Y-0.12%
OM growth 5Y1.81%
PM growth 3Y-12.1%
PM growth 5YN/A
GM growth 3Y0.2%
GM growth 5Y5.18%
COR Yearly Profit, Operating, Gross MarginsCOR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1 -1 2 3

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so COR is still creating some value.
The number of shares outstanding for COR has been reduced compared to 1 year ago.
Compared to 5 years ago, COR has less shares outstanding
COR has a worse debt/assets ratio than last year.
COR Yearly Shares OutstandingCOR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
COR Yearly Total Debt VS Total AssetsCOR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.2 Solvency

COR has an Altman-Z score of 4.91. This indicates that COR is financially healthy and has little risk of bankruptcy at the moment.
COR has a better Altman-Z score (4.91) than 84.16% of its industry peers.
COR has a debt to FCF ratio of 2.39. This is a good value and a sign of high solvency as COR would need 2.39 years to pay back of all of its debts.
COR has a better Debt to FCF ratio (2.39) than 76.24% of its industry peers.
A Debt/Equity ratio of 5.00 is on the high side and indicates that COR has dependencies on debt financing.
COR has a Debt to Equity ratio of 5.00. This is in the lower half of the industry: COR underperforms 78.22% of its industry peers.
Although COR does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 5
Debt/FCF 2.39
Altman-Z 4.91
ROIC/WACC1.63
WACC8.88%
COR Yearly LT Debt VS Equity VS FCFCOR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B

2.3 Liquidity

A Current Ratio of 0.90 indicates that COR may have some problems paying its short term obligations.
COR's Current ratio of 0.90 is on the low side compared to the rest of the industry. COR is outperformed by 75.25% of its industry peers.
A Quick Ratio of 0.55 indicates that COR may have some problems paying its short term obligations.
COR has a worse Quick ratio (0.55) than 83.17% of its industry peers.
Industry RankSector Rank
Current Ratio 0.9
Quick Ratio 0.55
COR Yearly Current Assets VS Current LiabilitesCOR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B 50B

6

3. Growth

3.1 Past

COR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.21%, which is quite good.
The Earnings Per Share has been growing by 15.14% on average over the past years. This is quite good.
The Revenue has grown by 9.31% in the past year. This is quite good.
COR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.09% yearly.
EPS 1Y (TTM)16.21%
EPS 3Y13.21%
EPS 5Y15.14%
EPS Q2Q%14.97%
Revenue 1Y (TTM)9.31%
Revenue growth 3Y10.43%
Revenue growth 5Y11.09%
Sales Q2Q%5.92%

3.2 Future

The Earnings Per Share is expected to grow by 10.82% on average over the next years. This is quite good.
The Revenue is expected to grow by 8.02% on average over the next years. This is quite good.
EPS Next Y11.31%
EPS Next 2Y11%
EPS Next 3Y10.78%
EPS Next 5Y10.82%
Revenue Next Year6.24%
Revenue Next 2Y6.43%
Revenue Next 3Y6.47%
Revenue Next 5Y8.02%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
COR Yearly Revenue VS EstimatesCOR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100B 200B 300B 400B
COR Yearly EPS VS EstimatesCOR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10 15 20 25

4

4. Valuation

4.1 Price/Earnings Ratio

COR is valuated rather expensively with a Price/Earnings ratio of 21.00.
Based on the Price/Earnings ratio, COR is valued a bit cheaper than 68.32% of the companies in the same industry.
COR is valuated rather cheaply when we compare the Price/Earnings ratio to 27.00, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 18.86, COR is valued on the expensive side.
COR's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. COR is cheaper than 65.35% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.70, COR is valued a bit cheaper.
Industry RankSector Rank
PE 21
Fwd PE 18.86
COR Price Earnings VS Forward Price EarningsCOR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

61.39% of the companies in the same industry are more expensive than COR, based on the Enterprise Value to EBITDA ratio.
68.32% of the companies in the same industry are more expensive than COR, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 20.31
EV/EBITDA 14.21
COR Per share dataCOR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 500 1K 1.5K

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates COR does not grow enough to justify the current Price/Earnings ratio.
COR has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.86
PEG (5Y)1.39
EPS Next 2Y11%
EPS Next 3Y10.78%

5

5. Dividend

5.1 Amount

With a yearly dividend of 0.71%, COR is not a good candidate for dividend investing.
COR's Dividend Yield is rather good when compared to the industry average which is at 0.60. COR pays more dividend than 83.17% of the companies in the same industry.
With a Dividend Yield of 0.71, COR pays less dividend than the S&P500 average, which is at 1.94.
Industry RankSector Rank
Dividend Yield 0.71%

5.2 History

The dividend of COR is nicely growing with an annual growth rate of 6.10%!
COR has been paying a dividend for at least 10 years, so it has a reliable track record.
COR has decreased its dividend in the last 3 years.
Dividend Growth(5Y)6.1%
Div Incr Years2
Div Non Decr Years2
COR Yearly Dividends per shareCOR Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

28.12% of the earnings are spent on dividend by COR. This is a low number and sustainable payout ratio.
COR's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP28.12%
EPS Next 2Y11%
EPS Next 3Y10.78%
COR Yearly Income VS Free CF VS DividendCOR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B
COR Dividend Payout.COR Dividend Payout, showing the Payout Ratio.COR Dividend Payout.PayoutRetained Earnings

CENCORA INC

NYSE:COR (1/8/2026, 8:04:00 PM)

After market: 339.2 +3.46 (+1.03%)

335.74

-4.67 (-1.37%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-05 2025-11-05/bmo
Earnings (Next)02-03 2026-02-03/bmo
Inst Owners95.74%
Inst Owner Change0%
Ins Owners0.09%
Ins Owner Change5.98%
Market Cap65.13B
Revenue(TTM)321.33B
Net Income(TTM)1.55B
Analysts80
Price Target393.22 (17.12%)
Short Float %2.62%
Short Ratio3.27
Dividend
Industry RankSector Rank
Dividend Yield 0.71%
Yearly Dividend2.25
Dividend Growth(5Y)6.1%
DP28.12%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.78%
Min EPS beat(2)0.41%
Max EPS beat(2)3.15%
EPS beat(4)4
Avg EPS beat(4)3.89%
Min EPS beat(4)0.41%
Max EPS beat(4)6.6%
EPS beat(8)8
Avg EPS beat(8)4.4%
EPS beat(12)12
Avg EPS beat(12)3.83%
EPS beat(16)15
Avg EPS beat(16)3.46%
Revenue beat(2)0
Avg Revenue beat(2)-0.51%
Min Revenue beat(2)-0.67%
Max Revenue beat(2)-0.35%
Revenue beat(4)1
Avg Revenue beat(4)0.16%
Min Revenue beat(4)-1.29%
Max Revenue beat(4)2.93%
Revenue beat(8)4
Avg Revenue beat(8)0.09%
Revenue beat(12)7
Avg Revenue beat(12)0.91%
Revenue beat(16)9
Avg Revenue beat(16)0.67%
PT rev (1m)1.22%
PT rev (3m)16.46%
EPS NQ rev (1m)-0.5%
EPS NQ rev (3m)-0.67%
EPS NY rev (1m)-0.22%
EPS NY rev (3m)0.96%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.52%
Revenue NY rev (1m)0.15%
Revenue NY rev (3m)-0.26%
Valuation
Industry RankSector Rank
PE 21
Fwd PE 18.86
P/S 0.2
P/FCF 20.31
P/OCF 16.81
P/B 43.19
P/tB N/A
EV/EBITDA 14.21
EPS(TTM)15.99
EY4.76%
EPS(NY)17.8
Fwd EY5.3%
FCF(TTM)16.53
FCFY4.92%
OCF(TTM)19.98
OCFY5.95%
SpS1656.44
BVpS7.77
TBVpS-82.18
PEG (NY)1.86
PEG (5Y)1.39
Graham Number52.88
Profitability
Industry RankSector Rank
ROA 2.03%
ROE 103.06%
ROCE 19.96%
ROIC 14.5%
ROICexc 18.88%
ROICexgc N/A
OM 1.17%
PM (TTM) 0.48%
GM 3.51%
FCFM 1%
ROA(3y)2.36%
ROA(5y)2.55%
ROE(3y)223.66%
ROE(5y)N/A
ROIC(3y)15.04%
ROIC(5y)14.55%
ROICexc(3y)19.39%
ROICexc(5y)18.79%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)20.71%
ROCE(5y)20.04%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-3.36%
ROICexc growth 5Y-5.64%
OM growth 3Y-0.12%
OM growth 5Y1.81%
PM growth 3Y-12.1%
PM growth 5YN/A
GM growth 3Y0.2%
GM growth 5Y5.18%
F-Score6
Asset Turnover4.2
Health
Industry RankSector Rank
Debt/Equity 5
Debt/FCF 2.39
Debt/EBITDA 1.57
Cap/Depr 62.52%
Cap/Sales 0.21%
Interest Coverage 10.51
Cash Conversion 80.48%
Profit Quality 206.36%
Current Ratio 0.9
Quick Ratio 0.55
Altman-Z 4.91
F-Score6
WACC8.88%
ROIC/WACC1.63
Cap/Depr(3y)50.93%
Cap/Depr(5y)61.57%
Cap/Sales(3y)0.18%
Cap/Sales(5y)0.19%
Profit Quality(3y)200.95%
Profit Quality(5y)175.46%
High Growth Momentum
Growth
EPS 1Y (TTM)16.21%
EPS 3Y13.21%
EPS 5Y15.14%
EPS Q2Q%14.97%
EPS Next Y11.31%
EPS Next 2Y11%
EPS Next 3Y10.78%
EPS Next 5Y10.82%
Revenue 1Y (TTM)9.31%
Revenue growth 3Y10.43%
Revenue growth 5Y11.09%
Sales Q2Q%5.92%
Revenue Next Year6.24%
Revenue Next 2Y6.43%
Revenue Next 3Y6.47%
Revenue Next 5Y8.02%
EBIT growth 1Y23.25%
EBIT growth 3Y10.3%
EBIT growth 5Y13.11%
EBIT Next Year23.57%
EBIT Next 3Y12.83%
EBIT Next 5YN/A
FCF growth 1Y6.99%
FCF growth 3Y13.28%
FCF growth 5Y11.79%
OCF growth 1Y11.2%
OCF growth 3Y12.76%
OCF growth 5Y11.92%

CENCORA INC / COR FAQ

What is the fundamental rating for COR stock?

ChartMill assigns a fundamental rating of 5 / 10 to COR.


What is the valuation status for COR stock?

ChartMill assigns a valuation rating of 4 / 10 to CENCORA INC (COR). This can be considered as Fairly Valued.


What is the profitability of COR stock?

CENCORA INC (COR) has a profitability rating of 6 / 10.


What is the valuation of CENCORA INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for CENCORA INC (COR) is 21 and the Price/Book (PB) ratio is 43.19.


What is the financial health of CENCORA INC (COR) stock?

The financial health rating of CENCORA INC (COR) is 5 / 10.